Innovative therapeutics

Investors

IR Snapshot

NASDAQBMRN
Beta1.39
Shares Outstanding179.6M
Average Volume (10 days)1.6M
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)($0.25)
Sales (TTM)$6.96
Book Value (MRQ)$17.12
Cash Flow (TTM)$0.23
Cash (MRQ)$4.02

Analyst Views

Current Mean RecommendationStrong Buy
Strong Buy14
 
Buy1
 
Hold2
 
Underperform0
 
Sell0
 

Recent Insider Transactions

Jean-Jacques Bienaime
Director, Chief Executive Officer
(8,000)
Sell
Jan 14, 2020
Jean-Jacques Bienaime
Director, Chief Executive Officer
(4,000)
Sell
Jan 8, 2020
Jean-Jacques Bienaime
Director, Chief Executive Officer
(3,000)
Sell
Jan 7, 2020
Jean-Jacques Bienaime
Director, Chief Executive Officer
(5,000)
Sell
Dec 27, 2019
Jean-Jacques Bienaime
Director, Chief Executive Officer
(3,000)
Sell
Dec 26, 2019

Recent SEC Filings

Insider Buy/Sell
Jan 16, 2020
Insider Buy/Sell
Jan 9, 2020
Insider Buy/Sell
Dec 30, 2019
Insider Buy/Sell
Dec 19, 2019
Insider Buy/Sell
Nov 27, 2019

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq®
Brineura®
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information